Use of Medroxyprogesterone Acetate in the Treatment of Müllerian Adenosarcoma: A Case Report

article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This case report details the treatment of a patient with Müllerian adenosarcoma using medroxyprogesterone acetate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BackgroundMüllerianadenosarcoma is a rare pelvic malignancy that most commonly arises from the endometrium. These tumors are relatively insensitive to chemotherapy and radiation and are primarily treated by surgical resection. We report a case of müllerian adenosarcoma arising outside of the uterus from a background of endometriosis treated with a combination of surgical resection and medroxyprogesterone acetate.CaseA 43-year-old woman with a history of endometriosis was diagnosed with advanced extrauterine müllerian adenosarcoma. After suboptimal tumor dubulking surgery she was treated with medroxyprogesterone acetate. Ten months postoperatively she remains without evidence of disease.ConclusionMedroxyprogesterone acetate may be a useful drug in the treatment of advanced müllerian adenosarcoma.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenosarcoma Antineoplastic Agents, Hormonal Genital Neoplasms, Female Medroxyprogesterone Acetate Mixed Tumor, Mullerian Adenosarcoma Adenosarcoma Adult Antineoplastic Agents, Hormonal Combined Modality Therapy Endometriosis Endometriosis Female Genital Neoplasms, Female Genital Neoplasms, Female Humans Medroxyprogesterone Acetate Mixed Tumor, Mullerian Mixed Tumor, Mullerian

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (4)

References (9)

Cited by (4)

Source provenance

europepmc
last seen: 2026-07-31T06:09:14.520117+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:07.520820+00:00
License: CC0 · commercial use OK